Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 10, 2015 5:33 AM ET

Healthcare Equipment and Supplies

Company Overview of Sera Prognostics, Inc.

Company Overview

Sera Prognostics, Inc., a biotechnology company, develops diagnostic and blood tests that help physicians to predict and manage preterm birth, preeclampsia, and other pregnancy complications. Sera Prognostics, Inc. has a strategic partnership with Agilent Technologies Inc. The company was founded in 2008 and is based in Salt Lake City, Utah.

2749 East Parleys Way

Suite 200

Salt Lake City, UT 84109

United States

Founded in 2008



Key Executives for Sera Prognostics, Inc.

Executive Chairman, Chief Executive Officer and President
Age: 62
Co-Founder, Managing Director of the Seed Fund Upstart Ventures and Director
Co-Founder and Co-Chairman of The Scientific Advisory Board
Co-Founder and Co-Chairman of Scientific Advisory Board
Chief Financial Officer
Age: 48
Compensation as of Fiscal Year 2015.

Sera Prognostics, Inc. Key Developments

Sera Prognostics, Inc. Announces Executive Changes

Sera Prognostics, Inc. announced that Arnold L. Oronsky, Ph.D., General Partner at InterWest Partners, LLC, was appointed to its board of directors. Dr. Oronsky's addition to the Sera Board occurs as the company is in the final stages of developing PreTRM, its novel proteomic predictor for preterm birth risk, prior to its commercial launch. As General Partner leading healthcare investments at InterWest Partners, Dr. Oronsky has significant experience investing in diagnostic and pharmaceutical companies. He has served on numerous boards of successful healthcare companies that address significant unmet medical needs through innovative technologies. The company also announced that Douglas Fisher, M.D., has recently resigned his position as a director on Sera's Board to join the company's management team as Chief Business Officer. Dr. Fisher has been a partner at InterWest Partners, serving on Sera's Board of Directors since November 2011. Dr. Fisher has focused on biopharmaceutical, diagnostic and medical device investments throughout his career, working in venture capital, consulting and pharmaceutical industries.

Square 1 Bank Announces Debt Facility to Sera Prognostics

Square 1 Bank announced that it has provided a $10 million debt facility to new client Sera Prognostics, Inc. Proceeds of the debt facility will provide working capital to help bolster commercialization efforts.

Sera Prognostics, Inc. Appoints Mansoor Raza Mirza to Its Board of Directors

Sera Prognostics, Inc. announced the appointment of Mansoor Raza Mirza to its Board of Directors. Dr. Mirza is Chief Oncologist at the Department of Oncology, Rigshospitalet - the Copenhagen University Hospital, Denmark. He currently serves as a director of Karyopharm Therapeutics and Metamark Genetics. Dr. Mirza chairs the Health Ministry's obligatory teaching course on non-surgical treatment of cancer for Danish doctors specializing in Clinical Oncology. He is vice-president of the Danish Gynecologic Cancer Group (DGCG) and medical director of Nordic Society of Gynecologic Oncology (NSGO).

Similar Private Companies By Industry

Company Name Region
Hardin Optical Company United States
GlobaleMed, LLC United States
Royal Dental Manufacturing, Inc. United States
Maine Molecular Quality Controls Inc. United States
Control-X Medical, Inc. United States

Recent Private Companies Transactions

Private Placement
November 7, 2014

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Sera Prognostics, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at